Repaglinide
Repaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell. It represents a new class of insulin secretagogues, structurally unrelated to sulphonylureas, which were developed for the treatment of type 2 diabetes.
Product Details
| Category |
Diabetes Research |
|---|---|
| Price | POA |
| CAS Number | 135062-02-1 |
| Formula | C27H36N2O4 |
| Molecular Weight | 452.59 |
| Purity | 98.0% |
| Appearance | white solid |
| Availability | In Stock |
| Storage Conditions | +4°C |
Product Enquiry
Send us your enquiry for Repaglinide. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Repaglinide email us and we will include your contribution on the website.
